The assessment of gastrin level and gastric histology in long-term PPI or vonoprazan users.

The assessment of gastrin level and gastric histology in long-term PPI or vonoprazan users. - The assessment of gastric histology in lon-term PPI users.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000028712

Enrollment

200

Registered

2017-12-01

Start date

2017-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

GERD patients with long-term PPI or vonoprazan using

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: GERD patients with long-term PPI or vonoprazan using

Exclusion criteria

Exclusion criteria: GERD patients with not continuous PPI or vonoprazan using( 1 year at least) stomach surgery sever liver failure, renal failure, heart failure.

Design outcomes

Primary

Measure	Time frame
gastric histology	—

Secondary

Measure	Time frame
long-term PPI or vonoprazan gastrin level, esophageal mucosal healing and symptom	—

Countries

Japan

Contacts

Public Contactkouichi Sakurai

Hattori Clinic Hattori Clinic

sakuraiko@jcom.zaq.ne.jp+81-96-325-2300

Outcome results